Advertisement
Screener

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Increase (Decrease) in Prepaid Expense

2.8 / 5 stars · 68/120 Roast Me

Corbus Pharmaceuticals Holdings, Inc. Increase (Decrease) in Prepaid Expense

Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Increase (Decrease) in Prepaid Expense of $1.38 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-07.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2023-11-07

  • Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in prepaid expense for the quarter ending 2023-09-30 was $678.11K.
  • Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in prepaid expense for the quarter ending 2023-06-30 was $137.46K.
  • Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in prepaid expense for the quarter ending 2023-03-31 was $561.22K.
  • Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in prepaid expense for the quarter ending 2022-12-31 was -$134.54K, a 153.15% decline year-over-year.
  • Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in prepaid expense for fiscal 2022 was -$1.57M.
  • Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in prepaid expense for fiscal 2021 was -$1.35M.
  • Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in prepaid expense for fiscal 2020 was -$346.81K, a 128.13% decline from fiscal 2019.
  • Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in prepaid expense for fiscal 2019 was $1.23M.
Period endIncrease (Decrease) in Prepaid Expense 3 monthIncrease (Decrease) in Prepaid Expense 3 month as first filedIncrease (Decrease) in Prepaid Expense 6 monthIncrease (Decrease) in Prepaid Expense 6 month as first filedIncrease (Decrease) in Prepaid Expense 9 monthIncrease (Decrease) in Prepaid Expense 12 month
2023-09-30$678.11K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
$815.57K
derived: sum of 2 quarters · filed 2023-11-07
$1.38M
10-Q · filed 2023-11-07
$1.24M
derived: sum of 4 quarters · filed 2023-11-07
2023-06-30$137.46K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
$698.68K
10-Q · filed 2023-08-08
$564.13K
derived: sum of 3 quarters · filed 2023-08-08
-$251.98K
derived: sum of 4 quarters · filed 2023-11-07
2023-03-31$561.22K
10-Q · filed 2023-05-09
$426.67K
derived: sum of 2 quarters · filed 2023-05-09
-$389.44K
derived: sum of 3 quarters · filed 2023-11-07
-$809.02K
derived: sum of 4 quarters · filed 2023-11-07
2022-12-31-$134.54K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07
-$950.66K
derived: sum of 2 quarters · filed 2023-11-07
-$1.37M
derived: sum of 3 quarters · filed 2023-11-07
-$1.57M
10-K · filed 2023-03-07
2022-09-30-$816.11K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
-$1.24M
derived: sum of 2 quarters · filed 2023-11-07
-$1.44M
10-Q · filed 2023-11-07
-$1.19M
derived: sum of 4 quarters · filed 2023-11-07
2022-06-30-$419.59K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
-$622.74K
10-Q · filed 2023-08-08
-$369.58K
derived: sum of 3 quarters · filed 2023-08-08
-$883.15K
derived: sum of 4 quarters · filed 2023-08-08
2022-03-31-$203.15K
10-Q · filed 2023-05-09
$50.00K
derived: sum of 2 quarters · filed 2023-05-09
-$463.56K
derived: sum of 3 quarters · filed 2023-05-09
-$1.50M
derived: sum of 4 quarters · filed 2023-05-09
2021-12-31$253.15K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07
-$260.42K
derived: sum of 2 quarters · filed 2023-03-07
-$1.29M
derived: sum of 3 quarters · filed 2023-03-07
-$1.35M
10-K · filed 2023-03-07
2021-09-30-$513.57K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
-$1.55M
derived: sum of 2 quarters · filed 2022-11-08
-$1.60M
10-Q · filed 2022-11-08
-$400.26K
derived: sum of 4 quarters · filed 2022-11-08
2021-06-30-$1.03M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
-$1.09M
10-Q · filed 2022-08-09
$113.30K
derived: sum of 3 quarters · filed 2022-08-09
-$581.59K
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31-$54.07K
10-Q · filed 2022-05-10
$1.15M
derived: sum of 2 quarters · filed 2022-05-10
$451.78K
derived: sum of 3 quarters · filed 2022-05-10
-$272.86K
derived: sum of 4 quarters · filed 2022-05-10
2020-12-31$1.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08
$505.85K
derived: sum of 2 quarters · filed 2022-03-08
-$218.79K
derived: sum of 3 quarters · filed 2022-03-08
-$346.81K
10-K · filed 2022-03-08
2020-09-30-$694.89K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
-$1.42M
derived: sum of 2 quarters · filed 2021-11-12
-$1.55M
10-Q · filed 2021-11-12
-$508.54K
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30-$724.63K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
-$852.66K
10-Q · filed 2021-08-12
$852.66K
10-Q · filed 2020-08-06
$186.35K
derived: sum of 3 quarters · filed 2021-08-12
$636.33K
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31-$128.02K
10-Q · filed 2021-05-13
$910.99K
derived: sum of 2 quarters · filed 2021-05-13
$1.36M
derived: sum of 3 quarters · filed 2021-05-13
$1.12M
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31$1.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15
$1.49M
derived: sum of 2 quarters · filed 2021-03-15
$1.24M
derived: sum of 3 quarters · filed 2021-03-15
$1.23M
10-K · filed 2021-03-15
2019-09-30$449.98K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-09
$204.89K
derived: sum of 2 quarters · filed 2020-11-09
$194.08K
10-Q · filed 2020-11-09
-$114.10K
derived: sum of 4 quarters · filed 2020-11-09
2019-06-30-$245.09K
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-08-31
-$255.90K
10-Q/A · filed 2020-08-31
-$564.08K
derived: sum of 3 quarters · filed 2020-08-31
-$640.31K
derived: sum of 4 quarters · filed 2020-08-31
2019-03-31-$10.81K
10-Q · filed 2020-05-11
$412.37K
10-Q · filed 2019-05-09
-$318.99K
derived: sum of 2 quarters · filed 2020-05-11
-$395.23K
derived: sum of 3 quarters · filed 2020-05-11
-$1.05M
derived: sum of 4 quarters · filed 2020-05-11
2018-12-31-$308.18K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
-$384.42K
derived: sum of 2 quarters · filed 2020-03-16
-$1.04M
derived: sum of 3 quarters · filed 2020-03-16
-$281.63K
10-K · filed 2020-03-16
2018-09-30-$76.24K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
-$731.24K
derived: sum of 2 quarters · filed 2019-11-07
$26.55K
10-Q · filed 2019-11-07
$2.11M
derived: sum of 4 quarters · filed 2019-11-07
2018-06-30-$655.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
$102.79K
10-Q · filed 2019-08-08
$2.19M
derived: sum of 3 quarters · filed 2019-08-08
$2.07M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31$757.79K
10-Q · filed 2019-05-09
$2.85M
derived: sum of 2 quarters · filed 2019-05-09
$2.72M
derived: sum of 3 quarters · filed 2019-05-09
$2.50M
derived: sum of 4 quarters · filed 2019-05-09
2017-12-31$2.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12
$1.96M
derived: sum of 2 quarters · filed 2019-03-12
$1.74M
derived: sum of 3 quarters · filed 2019-03-12
$1.88M
10-K · filed 2019-03-12
2017-09-30-$124.99K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
-$350.57K
derived: sum of 2 quarters · filed 2018-11-08
-$210.39K
10-Q · filed 2018-11-08
$404.07K
derived: sum of 4 quarters · filed 2018-11-08
2017-06-30-$225.59K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08
-$85.41K
10-Q · filed 2018-08-08
$529.06K
derived: sum of 3 quarters · filed 2018-08-08
$569.93K
derived: sum of 4 quarters · filed 2018-08-08
2017-03-31$140.18K
10-Q · filed 2018-05-10
$754.64K
derived: sum of 2 quarters · filed 2018-05-10
$795.52K
derived: sum of 3 quarters · filed 2018-05-10
$595.88K
derived: sum of 4 quarters · filed 2018-05-10
2016-12-31$614.46K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08
$655.34K
derived: sum of 2 quarters · filed 2017-11-08
$455.70K
derived: sum of 3 quarters · filed 2017-11-08
$553.75K
10-K · filed 2017-03-08
2016-09-30$40.88K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08
-$158.76K
derived: sum of 2 quarters · filed 2017-11-08
-$60.72K
10-Q · filed 2017-11-08
$217.42K
derived: sum of 4 quarters · filed 2017-11-08
2016-06-30-$199.64K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
-$101.60K
10-Q · filed 2017-08-09
$176.54K
derived: sum of 3 quarters · filed 2017-08-09
$25.78K
derived: sum of 4 quarters · filed 2017-08-09
2016-03-31$98.05K
10-Q · filed 2017-05-09
$376.18K
derived: sum of 2 quarters · filed 2017-05-09
$225.42K
derived: sum of 3 quarters · filed 2017-05-09
$263.81K
derived: sum of 4 quarters · filed 2017-05-09
2015-12-31$278.14K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08
$127.37K
derived: sum of 2 quarters · filed 2017-03-08
$165.76K
derived: sum of 3 quarters · filed 2017-03-08
$105.96K
10-K · filed 2017-03-08
2015-09-30-$150.77K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
-$112.38K
derived: sum of 2 quarters · filed 2016-11-10
-$172.18K
10-Q · filed 2016-11-10
$78.32K
derived: sum of 4 quarters · filed 2016-11-10
2015-06-30$38.39K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12
-$21.41K
10-Q · filed 2016-08-12
$229.09K
derived: sum of 3 quarters · filed 2016-08-12
$226.44K
derived: sum of 4 quarters · filed 2016-08-12
2015-03-31-$59.80K
10-Q · filed 2016-05-13
$190.70K
derived: sum of 2 quarters · filed 2016-05-13
$188.04K
derived: sum of 3 quarters · filed 2016-05-13
$180.56K
derived: sum of 4 quarters · filed 2016-05-13
2014-12-31$250.50K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28
$247.85K
derived: sum of 2 quarters · filed 2016-03-28
$240.37K
derived: sum of 3 quarters · filed 2016-03-28
$268.06K
10-K · filed 2016-03-28
2014-09-30-$2.65K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10
-$10.13K
derived: sum of 2 quarters · filed 2015-11-10
$17.55K
10-Q · filed 2015-11-10
2014-06-30-$7.48K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13
$20.21K
10-Q · filed 2015-08-13
2014-03-31$27.69K
10-Q · filed 2015-05-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Annexon, Inc. (ANNX)United States$0.147B-4.22
SPRUCE BIOSCIENCES, INC. (SPRB)United States$0.142B-2.89
Korro Bio, Inc. (KRRO)United States$0.141B-1.81
Atrium Therapeutics, Inc. (RNA)United States$0.140B
Curanex Pharmaceuticals Inc (CURX)United States$0.138B
TuHURA Biosciences, Inc./NV (HURA)United States$0.134B-4.88
Unicycive Therapeutics, Inc. (UNCY)United States$0.134B-3.70
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31
MEDICINOVA INC (MNOV)United States$0.130B-6.04
IMMUNIC, INC. (IMUX)United States$0.127B-1.88